Document Name | Bulletin Number | Date | View |
Benefit Status Effective April 1, 2025 | 34 | 2025-Mar-21 | Word PDF |
NIDPF Vol. 92 Supplement Effective April 1, 2025 - Refer to Bulletin #34 for Benefit Status | 33 | 2025-Mar-21 | Word PDF |
Online version of NIDPF Vol. 91 effective March 1, 2025 | 24 | 2025-Feb-28 | Word PDF |
Benefit Status Effective March 1, 2025 | 20 | 2025-Feb-20 | Word PDF |
NIDPF Vol. 91 Supplement Effective March 1, 2025 - Refer to Bulletin #20 for Benefit Status | 19 | 2025-Feb-20 | Word PDF |
Online version of NIDPF Vol. 91 effective February 1, 2025 | 10 | 2025-Jan-31 | Word PDF |
Benefit Status Effective February 1, 2025 | 8 | 2025-Jan-27 | Word PDF |
NIDPF Vol. 91 Supplement Effective February 1, 2025 - Refer to Bulletin #8 for Benefit Status | 7 | 2025-Jan-27 | Word PDF |
NIDPF Update: Delisting of Lanthanum 500mg, 750mg, and 1000mg Tablets | 1 | 2025-Jan-13 | Word PDF |
Online version of NIDPF Vol. 91 effective January 1, 2025 | 210 | 2024-Dec-31 | Word PDF |
Benefit Status Effective January 1, 2025 | 205 | 2024-Dec-19 | Word PDF |
NIDPF Vol. 91 Supplement Effective January 1, 2025 - Refer to Bulletin #205 for Benefit Status | 204 | 2024-Dec-19 | Word PDF |
NIDPF Update - Delisting of Alitretinoin 10mg and Alitretinoin 30mg | 196 | 2024-Dec-06 | Word PDF |
Online version of NIDPF Vol. 91 effective December 1, 2024 | 190 | 2024-Nov-29 | Word PDF |
Benefit Status Effective December 1, 2024 | 189 | 2024-Nov-21 | Word PDF |
NIDPF Vol. 91 Supplement Effective December 1, 2024 - Refer to Bulletin #189 for Benefit Status | 188 | 2024-Nov-21 | Word PDF |
Online version of NIDPF Vol. 91 effective November 1, 2024 | 180 | 2024-Nov-01 | Word PDF |
Benefit Status Effective November 1, 2024 | 177 | 2024-Oct-25 | Word PDF |
NIDPF Vol. 91 Supplement Effective November 1, 2024 - Refer to Bulletin #177 for Benefit Status | 176 | 2024-Oct-25 | Word PDF |
Online version of NIDPF Vol. 91 effective October 1, 2024 | 162 | 2024-Oct-01 | Word PDF |
|